Skip to main content
. Author manuscript; available in PMC: 2014 Dec 2.
Published in final edited form as: Clin Cancer Res. 2013 Nov 19;19(24):6891–6901. doi: 10.1158/1078-0432.CCR-13-1581

Figure 2.

Figure 2

HRs for the risk of death in subgroups based in the intent-to-treat population (A) and the PCWG2-defined subgroup of men with bone-metastatic disease (B). The dashes indicate that median survival has not been reached in that subgroup. Horizontal bars, 95% CIs.